All lobbying filings
Arnold & Porter Kaye Scholer LLP
Arnold & Porter Kaye Scholer LLP filed a Q3 report for Neurelis, Inc. on October 19, 2026, reporting no lobbying activity.
Lobbying for Neurelis, Inc. · Biopharmaceutical company specializing in treatments for neurological conditions.
Filing · LD-2 quarterly report
Q3 reportNo activity
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 19, 2026
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
California
Lobbying activity
0
No itemized activity in this filing.